54325 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Jul 08
00:20 UTC
|
CFG
Citizens Financial Group
|
◎ Target | Erika Najarian ★★★☆☆ #1789 | Buy | $75.00→ $82.00+9.3% |
|
Jul 08
00:20 UTC
|
CF
CF Industries
|
◎ Target | Vincent Andrews ★★★☆☆ #1699 | Equal Weight | $135.00→ $115.00-14.8% |
|
Jul 08
00:20 UTC
|
CENX
Century Aluminum
|
◎ Target | Nick Giles ★★★★☆ #512 | Buy | $86.00→ $74.00-14.0% |
|
Jul 08
00:20 UTC
|
CACI
CACI International
|
◎ Target | Gautam Khanna ★★★☆☆ #1840 | Buy | $625.00→ $550.00-12.0% |
|
Jul 08
00:20 UTC
|
CACC
Credit Acceptance
|
◎ Target | Moshe Orenbuch ★★☆☆☆ #2295 | Hold | $500.00→ $575.00+15.0% |
|
Jul 08
00:20 UTC
|
C
Citigroup
|
◎ Target | Ebrahim Poonawala ★★★☆☆ #1726 | Buy | $170.00→ $176.00+3.5% |
|
Jul 08
00:20 UTC
|
C
Citigroup
|
◎ Target | Erika Najarian ★★★☆☆ #1789 | Neutral | $134.00→ $150.00+11.9% |
|
Jul 08
00:20 UTC
|
BSBR
Banco Santander Brasil
|
◎ Target | Domingos Falavina not yet tracked | Overweight | $7.00→ $6.50-7.1% |
|
Jul 08
00:20 UTC
|
BRO
Brown & Brown
|
◎ Target | Alex Scott ★★★☆☆ #1864 | Equal Weight | $72.00→ $76.00+5.6% |
|
Jul 08
00:20 UTC
|
BRKR
Bruker
|
◎ Target | Puneet Souda ★★★★★ #108 | Outperform | $60.00→ $70.00+16.7% |
|
Jul 08
00:20 UTC
|
BPOP
Popular
|
◎ Target | Jared Shaw ★★☆☆☆ #2545 | Overweight | $180.00→ $185.00+2.8% |
|
Jul 08
00:20 UTC
|
BOH
Bank of Hawaii
|
◎ Target | Jared Shaw ★★☆☆☆ #2545 | Equal Weight | $86.00→ $88.00+2.3% |
|
Jul 08
00:20 UTC
|
BNZL
Bunzl
|
◎ Target | firm only | Sec→ r perform | GBX 2,200→ GBX 2,600+18.2% |
|
Jul 08
00:20 UTC
|
BNS
Bank of Nova Scotia
|
◎ Target | firm only | Hold | C$111.00→ C$121.00+9.0% |
|
Jul 08
00:20 UTC
|
BMRN
BioMarin Pharmaceutical
|
◎ Target | Luca Issi ★★★☆☆ #1373 | Sec→ r Perform | $66.00→ $62.00-6.1% |
|
Jul 08
00:20 UTC
|
BMO
Bank of Montreal
|
◎ Target | firm only | Buy | C$242.00→ C$265.00+9.5% |
|
Jul 08
00:20 UTC
|
BKU
BankUnited
|
◎ Target | Jared Shaw ★★☆☆☆ #2545 | Equal Weight | $53.00→ $52.00-1.9% |
|
Jul 08
00:20 UTC
|
BKG
The Berkeley Group
|
◎ Target | firm only | Buy | GBX 4,531→ GBX 4,517-0.3% |
|
Jul 08
00:20 UTC
|
BIIB
Biogen
|
◎ Target | Brian Abrahams ★★☆☆☆ #2651 | Outperform | $227.00→ $242.00+6.6% |
|
Jul 08
00:20 UTC
|
BFH
Bread Financial
|
◎ Target | Ryan Nash ★★★★★ #233 | Neutral | $94.00→ $108.00+14.9% |
|
Jul 08
00:20 UTC
|
BFH
Bread Financial
|
◎ Target | Moshe Orenbuch ★★☆☆☆ #2295 | Hold | $95.00→ $103.00+8.4% |
|
Jul 08
00:20 UTC
|
BFH
Bread Financial
|
◎ Target | Nicholas Holowko ★★★★★ #249 | Buy | $94.00→ $120.00+27.7% |
|
Jul 08
00:20 UTC
|
BCRX
BioCryst Pharmaceuticals
|
◎ Target | Brian Abrahams ★★☆☆☆ #2651 | Outperform | $13.00→ $14.00+7.7% |
|
Jul 08
00:20 UTC
|
BCE
BCE
|
◎ Target | firm only | Sec→ r Outperform | C$41.00→ C$39.00-4.9% |
|
Jul 08
00:20 UTC
|
BAH
Booz Allen Hamilton
|
◎ Target | Gautam Khanna ★★★☆☆ #1840 | Hold | $85.00→ $70.00-17.6% |
|
Jul 08
00:20 UTC
|
BAC
Bank of America
|
◎ Target | Erika Najarian ★★★☆☆ #1789 | Buy | $63.00→ $68.00+7.9% |
|
Jul 08
00:20 UTC
|
AXSM
Axsome Therapeutics
|
◎ Target | Leonid Timashev ★★☆☆☆ #2314 | Outperform | $302.00→ $304.00+0.7% |
|
Jul 08
00:20 UTC
|
AXP
American Express
|
◎ Target | Erika Najarian ★★★☆☆ #1789 | Neutral | $340.00→ $386.00+13.5% |
|
Jul 08
00:20 UTC
|
AXP
American Express
|
◎ Target | Moshe Orenbuch ★★☆☆☆ #2295 | Hold | $330.00→ $338.00+2.4% |
|
Jul 08
00:20 UTC
|
AXP
American Express
|
◎ Target | Terry Ma ★★☆☆☆ #2506 | Equal Weight | $322.00→ $364.00+13.0% |
|
Jul 08
00:20 UTC
|
ASND
Ascendis Pharma A/S
|
◎ Target | Luca Issi ★★★☆☆ #1373 | Outperform | $275.00→ $280.00+1.8% |
|
Jul 08
00:20 UTC
|
ASIC
Ategrity Specialty
|
◎ Target | Alex Scott ★★★☆☆ #1864 | Overweight | $26.00→ $28.00+7.7% |
|
Jul 08
00:20 UTC
|
ASB
Associated Banc
|
◎ Target | Jared Shaw ★★☆☆☆ #2545 | Overweight | $33.00→ $34.00+3.0% |
|
Jul 08
00:20 UTC
|
ARGX
argenex
|
◎ Target | Luca Issi ★★★☆☆ #1373 | Outperform | $890.00→ $945.00+6.2% |
|
Jul 08
00:20 UTC
|
ARCB
ArcBest
|
◎ Target | Thomas Wadewitz ★★★☆☆ #1358 | Neutral | $122.00→ $145.00+18.9% |
|
Jul 08
00:20 UTC
|
APTV
Aptiv
|
◎ Target | Edison Yu ★★★★☆ #971 | Buy | $74.00→ $75.00+1.4% |
|
Jul 08
00:20 UTC
|
APP
AppLovin
|
◎ Target | Alec Brondolo ★★☆☆☆ #2333 | Overweight | $571.00→ $575.00+0.7% |
|
Jul 08
00:20 UTC
|
AON
AON
|
◎ Target | Alex Scott ★★★☆☆ #1864 | Equal Weight | $372.00→ $382.00+2.7% |
|
Jul 08
00:20 UTC
|
AMGN
Amgen
|
◎ Target | Gregory Renza ★★☆☆☆ #2665 | Hold | $327.00→ $340.00+4.0% |
|
Jul 08
00:20 UTC
|
ALL
Allstate
|
◎ Target | Alex Scott ★★★☆☆ #1864 | Underweight | $203.00→ $213.00+4.9% |
|
Jul 08
00:20 UTC
|
ALK
Alaska Air Group
|
◎ Target | Christopher Stathoulopoulos ★★★☆☆ #1134 | Positive | $50.00→ $70.00+40.0% |
|
Jul 08
00:20 UTC
|
ALGT
Allegiant Travel
|
◎ Target | Christopher Stathoulopoulos ★★★☆☆ #1134 | Neutral | $85.00→ $132.00+55.3% |
|
Jul 08
00:20 UTC
|
AJG
Arthur J. Gallagher & Co.
|
◎ Target | Alex Scott ★★★☆☆ #1864 | Overweight | $275.00→ $292.00+6.2% |
|
Jul 08
00:20 UTC
|
AGIO
Agios Pharmaceuticals
|
◎ Target | Luca Issi ★★★☆☆ #1373 | Sec→ r Perform | $28.00→ $32.00+14.3% |
|
Jul 08
00:20 UTC
|
AGIO
Agios Pharmaceuticals
|
◎ Target | Alec Stranahan ★★☆☆☆ #2345 | Buy | $40.00→ $46.00+15.0% |
|
Jul 08
00:20 UTC
|
AGIO
Agios Pharmaceuticals
|
◎ Target | Gregory Renza ★★☆☆☆ #2665 | Buy | $36.00→ $41.00+13.9% |
|
Jul 08
00:20 UTC
|
AFRM
Affirm
|
◎ Target | Moshe Orenbuch ★★☆☆☆ #2295 | Buy | $90.00→ $117.00+30.0% |
|
Jul 08
00:20 UTC
|
AFL
Aflac
|
◎ Target | Alex Scott ★★★☆☆ #1864 | Underweight | $99.00→ $98.00-1.0% |
|
Jul 08
00:20 UTC
|
AER
Aercap
|
◎ Target | Terry Ma ★★☆☆☆ #2506 | Overweight | $164.00→ $179.00+9.1% |
|
Jul 08
00:20 UTC
|
AER
Aercap
|
◎ Target | Christopher Stathoulopoulos ★★★☆☆ #1134 | Positive | $170.00→ $176.00+3.5% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.